Introduction {#s1}
============

Retinal degeneration due to photoreceptor loss is a major threat to human health as progressive vision loss severely interferes with a person's daily activities. Such photoreceptor cell loss is common to a number of degenerative eye disorders including cone dystrophy, retinitis pigmentosa (RP) and the highly prevalent age-related macular degeneration (AMD) ([@bib38]; [@bib39]; [@bib62]). Each of these disorders is influenced, to various degrees, by mutations in a number of distinct genes. RP, for instance, has been associated with mutations in about 80 genes and can be inherited as an autosomal-dominant, autosomal-recessive, or X-linked trait ([@bib10]). It is characterized initially by degeneration of rod photoreceptors, followed by a loss of cone photoreceptors and of the photoreceptor-trophic retinal pigment epithelium (RPE). Consequently, patients suffer from progressive night blindness, tunnel vision and, rarely, may become totally blind ([@bib10]; [@bib20]).

Currently, one of the major challenges for the field of retinal degenerative diseases is to provide strategies to prevent or delay the onset of photoreceptor cell loss. Several approaches are currently under investigation to treat vision loss in patients suffering from retinal degenerations, including retinal prostheses implants, stem cell transplants and gene therapy ([@bib15]; [@bib48]). Although gene therapy has recently been approved for a specific causative mutation (RPE65) ([@bib46]), there are still no broadly applicable and efficacious treatments available to prevent or cure vision loss caused by photoreceptor degeneration. Alternatively, photoreceptor cell death could be prevented by strengthening endogenous prosurvival mechanisms or by directly blocking cell death ([@bib43]; [@bib54]). In fact, several neuroprotective factors have been identified based on results obtained with transgenic and conditional knockout animals and pharmacological treatments ([@bib26]; [@bib55]). They include ciliary neurotrophic factor (CNTF), glial cell--derived neurotrophic factor (GDNF), pigment epithelium-derived factor (PEDF) and rod-derived cone viability factor (RdCVF), all of which might potentially be used to treat photoreceptor degeneration in humans ([@bib1]; [@bib6]; [@bib9]; [@bib59]). Their clinical application, however, is hampered by relatively short half-lives, systemic side effects and reduced efficacy, and none are commercially available for clinical use ([@bib43]; [@bib48]). Therefore, there is a need to identify additional factors that are capable of improving photoreceptor survival and that may have pharmacokinetic properties that differ from those already studied.

Retinal degeneration, regardless of whether it is due to intrinsic genetic or extrinsic environmental conditions, is normally associated with an induction of damaging effector molecules. As a corollary of damage, the eye may respond with the induction of damage-limiting, endogenous neuroprotective factors such as the ones mentioned above ([@bib16]; [@bib44]). This fact prompted us to search for additional neuroprotective factors after experimental light damage (LD). It is known that limited light stress activates the FGF2/gp130 signaling pathway ([@bib37]; [@bib55]) and that prolonged exposure to light upregulates CNTF and FGF2, although usually at levels too low to protect against retinal degeneration ([@bib30]; [@bib57]). That LD is a valid strategy to identify novel retinoprotective factors is underscored by the role excessive light may play in worsening genetically influenced retinal degenerations such as AMD ([@bib41]; [@bib51]).

To discover novel retinoprotective factors, we applied an RNA-seq analysis to mouse neural retinas after prolonged LD. This approach confirmed the induction of a number of genes previously found to be altered during LD ([@bib19]; [@bib45]; [@bib47]) and identified a number of novel genes not previously recognized in this context. One of them is *Kit ligand* (*Kitl*) whose protein product, KITL (also known as stem cell factor, SCF, or mast cell growth factor, MGF), stimulates an important signaling pathway by interacting with its receptor, KIT (also known as the proto-oncogene c-KIT) and promotes cell survival, migration and proliferation ([@bib24]; [@bib31]; [@bib34]). KIT is a multi-domain transmembrane tyrosine kinase expressed in a variety of cell types including melanocytes, germ cells and cells of the hematopoietic lineage, and is required for their normal development and function ([@bib4]; [@bib7]; [@bib22]; [@bib66]). Interaction of KIT with its ligand leads to receptor dimerization and autophosphorylation which in turn activates the MAPK pathway, phosphatidylinositol 3'-kinase (PI3K), JAK/STAT and SRC family members ([@bib24]; [@bib31]). In mice, loss-of-function mutations in *Kit* cause severe anemia, pigmentation abnormalities, sterility, mast cell deficits, spatial learning memory deficits and defects in peripheral nerve regeneration ([@bib17]; [@bib40]; [@bib58]; [@bib68]). Nevertheless, although KIT has been found to be expressed in retinal progenitor cells ([@bib28]; [@bib67]), its functional role in the adult retina is still unknown.

Here, we find that mice homozygous for the *Kit^Wps^* mutation ([@bib18]) show an exacerbated photoreceptor degeneration and that overexpression of KITL can prevent photoreceptor cell death in light-damaged mice. Furthermore, we show that KIT signaling stimulates the expression of *Hmox1* in an NRF2-dependent manner and that experimental expression of *Hmox1* in *Kit^Wps^* homozygotes prevents light-induced photoreceptor degeneration. Furthermore, we show that overexpression of KITL prevents photoreceptor cell death and partially rescues the retinal dysfunction in mouse genetic models of retinitis pigmentosa. Hence, our findings suggest a mechanism by which KITL/KIT signaling contributes to protection of photoreceptor cells from degeneration and which may potentially lead to novel therapeutic strategies in retinal degenerative disorders.

Results {#s2}
=======

Light damage upregulates endogenous KITL in photoreceptor cells {#s2-1}
---------------------------------------------------------------

Previous results have shown that light stress induces endogenous factors in the eye that are capable of protecting photoreceptor cells ([@bib37]; [@bib55]). Hence, we used LD in light sensitive BALB/c albino mice to search for such inducible factors. Retinal damage is usually accompanied by reactive gliosis, characterized by the accumulation of filamentous proteins such as glial fibrillary acidic protein (GFAP) and formation of a glial scar ([@bib13]). As shown in [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}, after 1 day of continuous exposure (15,000 Lux), BALB/c neural retinas showed no obvious signs of retinal degeneration, but increased expression of GFAP. After three days of continuous exposure, however, there was significant retinal degeneration ([Figure 1---figure supplement 1A to C](#fig1s1){ref-type="fig"}). Therefore, we used the 1-day exposure to identify novel protective genes ([Figure 1A](#fig1){ref-type="fig"}) and longer exposures to test for effects on late-stage damage. Whole neural retinas were subjected to RNA-seq analysis. The RNA-seq data showed a large number of genes whose expression was significantly changed (*p* adjust value \<0.01 and fold change \>2) in the LD-treated neural retinas compared with the non-treated ones ([Figure 1A](#fig1){ref-type="fig"}). These genes included known light-inducible ones such as *Gfap, Edn2, Fgf2, Ccl3* and *Ccl12* ([Figure 1B](#fig1){ref-type="fig"}) and hence supported the validity of this approach ([@bib19]; [@bib45]; [@bib47]). A KEGG (Kyoto Encyclopedia of Genes and Genomes) analysis identified the MAPK pathway among the top 20 altered signaling pathways ([Figure 1C](#fig1){ref-type="fig"}), with increased expression, for instance, of the genes encoding LIF, KITL and NGF ([Figure 1D](#fig1){ref-type="fig"}). RT-PCR confirmed their differential expression identified by the RNA-seq analysis. In particular, *Kitl* expression was significantly increased in the neural retina after LD ([Figure 1---figure supplement 1D](#fig1s1){ref-type="fig"}). Because KIT signaling plays vital roles in a variety of cell types, we focused on this pathway in the retina. Quantitation of western blot bands showed that both mature transmembrane and cleaved soluble forms of KITL (45 and 19 kDa, respectively) were increased (m-KITL, 2.4 ± 0.9 fold; s-KITL, 4.5 ± 1.6 fold; n = 5) ([Figure 1E,F](#fig1){ref-type="fig"}). Phosphorylated KIT (indicative of activated KIT), although not total KIT, was also increased (3.14 ± 0.94, n = 5) ([Figure 1G,H](#fig1){ref-type="fig"}). Immunostaining showed that upregulation of KITL was predominantly seen in photoreceptor inner segments ([Figure 1I](#fig1){ref-type="fig"}). These results suggest that following prolonged light exposure, upregulation of KITL leads to activation of KIT signaling.

![Light damage induces increased expression of KITL and activation of KIT in mouse retina.\
(**A**) Schematic representation of time frame and analysis of light damage (LD). Two-month-old albino mice were raised in the dark for 12 hr and then exposed to constant white light of 15,000 lux for 1 day to induce retinal damage. The volcano map of transcriptome analysis shows a global view of gene expression. (**B**) Heat map of the selective LD-induced differentially expressed reported genes. The columns for NL (normal light) or LD represent the results from five biological replicates. (**C**) The bar graph of KEGG analysis shows the top 20 differentially activated signaling pathways. (**D**) Heat map shows the differentially expressed genes of the MAPK pathway. (**E**) Western blotting analysis of KITL in retinas after LD. (**F**) Quantification of western blot bands shows the expression levels of the KITL. Note that both the 19 kDa and 45 kDa isoforms of KITL were upregulated by LD. (**G**) Western blot analysis of the tyrosinase kinase receptor KIT (upper panels) and its phosphorylated form (lower panels) in the retinas after LD. (**H**) Quantification of western blot bands show the expression levels of KIT and its phosphorylation levels. Note that p-KIT was upregulated by LD. (**I**) Immunostaining of light-treated retina detected by anti-KITL antibody. Each image is representative of at least five retinas. IS, photoreceptor inner segments; ONL, outer nuclear layer; OS, photoreceptor outer segments. \*\* indicates p\<0.01. Scale bar, 50 μm.](elife-51698-fig1){#fig1}

The above immunostaining data showed that KITL expression was hardly detectable in RPE cells under normal or even LD condition ([Figure 1I](#fig1){ref-type="fig"}). Nevertheless, given that the retinal pigment epithelium (RPE) secrets neurotrophic factors to support photoreceptor cells, we examined in more detail whether the RPE might contribute to KITL expression under normal or LD conditions. To this end, we separately isolated the RPE and neural retina as shown in [Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"}. Quantitative PCR data showed higher *Kitl* expression in the neural retina (14.6 ± 7.2 fold, n = 3) compared to RPE ([Figure 1---figure supplement 2B](#fig1s2){ref-type="fig"}). Furthermore, upon LD, *Kitl* was upregulated in neural retinas (6.7 ± 1.2 fold compared to normal light condition, n = 3) but hardly in RPE (1.24 ± 0.36 fold compared to normal light condition, n = 3) ([Figure 1---figure supplement 2C,D](#fig1s2){ref-type="fig"}). To test for protein expression, we further dissected the neural retina to yield photoreceptor tissue as schematically shown in [Figure 1---figure supplement 3A](#fig1s3){ref-type="fig"}. Western blot data showed that under normal light conditions, the level of KITL protein was 5.11 ± 0.29 fold higher in the photoreceptor tissue compared to RPE (based on three independent samples) ([Figure 1---figure supplement 3B,C](#fig1s3){ref-type="fig"}). These results were supported by in situ hybridization (ISH), showing that light stress significantly increased the *Kitl* signal in photoreceptor cells but not in RPE cells ([Figure 1---figure supplement 3D](#fig1s3){ref-type="fig"}). Hence, the data suggest that photoreceptor cells rather than RPE cells are the major source of increased *Kitl* expression following light stress.

The *Kit^Wps^* mutation does not cause detectable changes in retinal function and structure but disrupts KIT activation in the retina {#s2-2}
-------------------------------------------------------------------------------------------------------------------------------------

To determine whether upregulation of KIT signaling has any functional relevance during excessive light exposure, we used mice harboring a mutant *Kit* allele on a C57BL/6J background, *Kit^Wps^*. This allele encodes a KIT protein with an Asp-to-Asn (D-to-N) mutation at residue 60 in the extracellular domain that reduces, but does not completely eliminate, KIT signaling. Consequently, *Kit^Wps^* homozygotes are viable, although they are totally white and infertile ([@bib18]). Nevertheless, *Kit^Wps^* homozygotes have no detectable changes in fundus, such as blood vessels and the pigmentation, similar to other point mutations in *Kit* ([@bib3]; [Figure 2A](#fig2){ref-type="fig"}). Moreover, the amplitudes of the a- and b-waves under scotopic or photopic conditions are not significantly different between *Kit^+/+^* and *Kit^Wps/Wps^* mice ([Figure 2B,C](#fig2){ref-type="fig"}), and *Kit^Wps/Wps^* retinas appear structurally intact ([Figure 2D](#fig2){ref-type="fig"}). Also, the numbers of cell nuclei in the ganglion cell layer (GCL), inner nuclear layer (INL) and outer nuclear layer (ONL) were similar to those in *Kit^+/+^* retinas ([Figure 2E](#fig2){ref-type="fig"}) and immunoreactivities for markers for bipolar cells (OTX2), 'On' bipolar cells (PKCα), rod photoreceptor cells (Rhodopsin) and cone photoreceptor cells (Opsin) were as in *Kit^+/+^* retinas ([Figure 2F](#fig2){ref-type="fig"}). Likewise, there was also no significant difference in the number of bipolar cells and cone photoreceptor cells ([Figure 2F,G](#fig2){ref-type="fig"}). These data show that under normal conditions, the *Kit^Wps^* mutation does not cause detectable changes in retinal function, histology, or structure.

![No changes in retinal cell distribution and structure, but disruption of Kit activation in *Kit^Wps^*^/*Wps*^ retina.\
(**A**) Fundus images of 2-month-old *Kit^+/+^* and *Kit^Wps/Wps^* mice. (**B**) ERG traces of *Kit^+/+^* (left panels) and *Kit^Wps/Wps^* (right panels) retinas under scotopic (upper panels) and photopic conditions (lower panels). (**C**) Quantification of ERG amplitudes under scotopic and photopic conditions. (**D, E**) Histological images of H and E staining from 2-month-old *Kit^+/+^* and *Kit^Wps/Wps^* retinas (**D**) and quantification showing the mean number of nuclei localized at GCL, INL, and ONL over the length of 0.35 mm between 300 μm to 700 μm from the optic nerve head in dorsal retina of *Kit^+/+^* and *Kit^Wps/Wps^* mice (n = 5) (**E**). Representative histological sections are from superior retinas 0.3 mm from the optic nerve head. (**F**) Immunohistochemistry for OTX2, PKCα, Opsin and Rhodopsin in 2-month-old *Kit^+/+^* and *Kit^Wps/Wps^* retinas. (**G**) Quantification of OTX2+, PKCα+ and Opsin+ cells in the indicated retinas. Each image is representative for at least five retinas. The analyzed sectional numbers are from at least 30 sections from at least five retinas. (**H**) Schematic representation of KIT protein structure and the location recognized by the ACK45 antibody (left panels) and immunostaining images of ACK45 antibody in 3-month-old *Kit^+/+^* and *Kit^Wps/Wps^* retinas (right panels). (**I**) Western blots show phosphorylation of KIT, ERK and AKT in *Kit^+/+^* and *Kit^Wps/Wps^* retinas after the injection of KITL (5.6 nM) at the indicated time points. (**J**) Quantification of western blot bands shows the phosphorylation levels of KIT, ERK and AKT. GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; IS, photoreceptor inner segments; ONL, outer nuclear layer; OS, photoreceptor outer segments. Arrows in panels H indicate KIT-positive signal. \* or \*\* indicates p\<0.05 or p\<0.01. Scale bar, 50 μm.\
Figure 2---source data 1.Source data for the graphs in Figure 2C.](elife-51698-fig2){#fig2}

We next assessed whether the mutation would interfere with KIT signaling in the retina. As shown in [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}, western blots and immunostaining using the AB5506 antibody (recognizing the intracellular kinase domain of KIT) did not detect differences in KIT expression levels between *Kit^+/+^* and *Kit^Wps^* homozygous retinas. However, immunostaining using the ACK45 antibody (recognizing the extracellular immunoglobulin domain of wild type, although not *Wps/Wps* KIT protein) showed a significantly decreased immunoreactivity in the photoreceptor layer, the inner plexiform layer and the ganglion cell layer of *Kit^Wps/Wps^* retinas ([Figure 2H](#fig2){ref-type="fig"}). It is unlikely that the KIT immunoreactivity in the photoreceptor layer stems from interdigitating apical microvilli of Müller glial cells as double immunostaining with ACK45 and an antibody against the Müller glia-specific EAAT1 protein in 2-month-old C57BL/6J mice did not show any overlapping signals. Furthermore, the KIT signal was drastically reduced in mice homozygous for a retinal degeneration allele (*rd10/rd10*) which almost totally lack photoreceptor cells but not Müller glia cells ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}).

As the *Wps* mutation lies in the first immunoglobulin domain of KIT, which is required for the interaction with KITL, it was likely that it would impair KIT activation by KITL not only in extraocular cells but also in the retina. Indeed, upon intravitreal injection of KITL, phosphorylation of KIT and its downstream targets ERK and AKT were prominent in *Kit^+/+^* but not in *Kit^Wps/Wps^* retinas ([Figure 2I,J](#fig2){ref-type="fig"}). These results indicate that the mutation substantially reduced activation of KIT by KITL in the neural retina.

Disruption of KIT signaling aggravates retinal dysfunction and exacerbates retinal degeneration after LD {#s2-3}
--------------------------------------------------------------------------------------------------------

The above results prompted us to use the above *Kit^Wps/Wps^* mice on a C57BL/6J background to gain insights into the role of KIT signaling specifically during LD of the retina. Even though C57BL/6J mice express the Leu450-Met variant of RPE65 and show reduced susceptibility to LD ([@bib60]), they have been used as a suitable model of light-induce retinal damage (LIRD) because their susceptibility to LD is similar to that of humans ([@bib11]). Thus, we first dark-adapted *Kit^+/+^* and *Kit^Wps/Wps^* mice and examined them by electroretinography (ERG). Subsequently, the mice were light-exposed (15,000 lux) for 8 days, with pupils dilated by a mydriatic agent once a day, and then re-examined by ERG ([Figure 3A](#fig3){ref-type="fig"}). As shown in [Figure 3B and C](#fig3){ref-type="fig"}, under scotopic conditions (rod response), the a- and b-wave amplitudes were similar in *Kit^+/+^* and *Kit^Wps/Wps^* mice under normal light (426 ± 58μV and 837 ± 1314μV, respectively, in *Kit^+/+^*, n = 8; and 439 ± 83μV and 863 ± 114μV, respectively, in *Kit^Wps/Wps^* mice, n = 8). After LD, the a- and b-wave amplitudes declined in *Kit^+/+^* to 294 ± 37μV and 521 ± 27μV, respectively (n = 8) and in *Kit^Wps/Wps^* mice to 188 ± 80μV and 365 ± 63μV, respectively (n = 8). These data indicate that the rod-driven circuit was damaged more severely in *Kit^Wps/Wps^* retinas compared to *Kit^+/+^* retinas. Similarly, under photopic conditions (cone response) ([Figure 3B,D](#fig3){ref-type="fig"}), the b-wave ERG responses were weakened in *Kit^Wps/Wps^* mice more severely (from 89.4 ± 15μV to 40 ± 10μV, n = 8) than those in *Kit^+/+^* mice (from 95 ± 13μV to 61 ± 9μV, n = 8), indicating that the cone-driven circuit was also damaged more severely in *Kit^Wps/Wps^* retinas. These results suggest that normal KIT signaling helps to protect against retinal damage following LD.

![*Kit^Wps^* mutation significantly damages retinal function and accelerates retinal degeneration during LD.\
(**A**) Schematic representation of LD treatment of mice for B-G. Three-month-old *Kit^+/+^* and *Kit^Wps/Wps^* mice were raised in the dark for one day, and then exposed to constant high intensity light of 15,000 lux for 8 days with mydriasis treatment to induce retinal damage. Retinal functions were subsequently assessed by electroretinography (ERG) after one day dark adaptation. (**B**) ERG traces of *Kit^+/+^* (left panels) and *Kit^Wps/Wps^* (right panels) retinas before and after LD treatment under scotopic (upper panels) and photopic conditions (lower panels). Note that both scotopic and photopic responses of the *Kit^Wps/Wps^* retinas were similar to those of *Kit^+/+^* retinas with normal light (NL). Usually, the scotopic ERG result is shown as step-wise figure. (**C and D**) Quantification of ERG amplitudes under scotopic (**C**) and photopic conditions (**D**). Note that both scotopic and photopic responses of *Kit^Wps/Wps^* retinas were impaired more severely than those in *Kit^+/+^* retinas. Each trace is the average of individual records from at least five mice. (**E**) Retinal degeneration analysis of *Kit^+/+^* and *Kit^Wps/Wps^* mice before and after LD treatment by HE staining (**a**), GFAP staining (**b**), Rhodopsin staining (**c**) and TUNEL detection (**d**). Arrows point to the weakened signal or abnormal translocation signal of the rhodopsin (**c**) and dead cells (**d**). (**F**) The curve diagram shows the thickness of ONL from *Kit^+/+^* and *Kit^Wps/Wps^* retinas under NL or high-intensity LD conditions. (**G**) Quantification of the number of TUNEL-positive cells in the ONL. GCL, ganglion cell layer; I, inferior; INL, inner nuclear layer; IS, photoreceptor inner segments; ONL, outer nuclear layer; S, superior. \*\* indicates p\<0.01. Scale bar, 50 μm.\
Figure 3---source data 1.Source data for the graphs in Figure 3C, D, G and the diagram in Figure 3F.](elife-51698-fig3){#fig3}

Retinal degeneration analysis revealed that along with the reduction of the electrical responses, LD also led to significant morphological changes, reactive gliosis, Rhodopsin translocation and photoreceptor cell death. As shown in [Figure 3E](#fig3){ref-type="fig"}, compared to light-damaged *Kit^+/+^* retinas, similarly treated *Kit^Wps/Wps^* retinas showed a severely reduced thickness of the ONL both in superior and inferior regions ([Figure 3E](#fig3){ref-type="fig"}, panels a, ***F***). In unstressed *Kit^+/+^* or mutant retinas, GFAP immunoreactivity, indicative of reactive gliosis, was only detected in the ganglion cell layer, while after light stress, Müller glial cells also became positive for GFAP, but much more so in *Kit^Wps/Wps^* compared to *Kit^+/+^* mice ([Figure 3E](#fig3){ref-type="fig"}, panels b). Likewise, Rhodopsin immunoreactivity was not only more severely reduced in light-damaged *Kit^Wps/Wps^* compared to *Kit^+/+^* retinas but also showed abnormal presence in the ONL ([Figure 3E](#fig3){ref-type="fig"}, arrows in panels c). These results were consistent with TUNEL assays to evaluate cell death. As shown in [Figure 3E](#fig3){ref-type="fig"} (panels D) and 3G, although dead cells were present in the ONL of *Kit^+/+^* retinas (22 ± 7 per section, n = 10), their number was much higher in *Kit^Wps/Wps^* retinas (44 ± 9, n = 10). Hence, these data show that after excessive light exposure, the photoreceptor cells of *Kit^Wps/Wps^* mice are not only structurally but also functionally impaired to a greater extent than those of *Kit^+/+^* mice. The findings indicate that the *Kit^Wps^* mutation accelerates photoreceptor degeneration during LD.

KITL prevents photoreceptor cell death-associated with LD {#s2-4}
---------------------------------------------------------

As the above results indicated a role for KIT signaling in light-induced photoreceptor degeneration, we asked whether KITL may play a protective role in LD. Hence, we overexpressed KITL by intraocular injection of an engineered AAV virus. We first tested in which retinal areas an AAV8-CMV-GFP vector ([Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}) is expressed by scanning fluorescent ophthalmoscopy and by optical coherence tomography. Fourteen days after virus infection, fundus photographs showed that GFP was found in nearly the entire retina, and cross-sections showed strong GFP signals in photoreceptor cells ([Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}). We then ectopically expressed KITL using an appropriately engineered viral expression vector, AAV8-CMV-KITL (hereafter called AAV8-KITL, schematically shown in [Figure 4A](#fig4){ref-type="fig"}). Two weeks after infection, we isolated the neural retinas and examined them for KITL expression. Western blots showed a significantly increased expression of KITL (3.3 ± 0.46 fold over uninjected control, n = 4) ([Figure 4B](#fig4){ref-type="fig"}), and immunostaining showed that overexpression of KITL was almost entirely restricted to photoreceptors in the retinas ([Figure 4C](#fig4){ref-type="fig"}). These results indicated that KITL can be successfully overexpressed in photoreceptor cells.

![Overexpression of KITL by AAV8-KITL virus prevents light-induced retinal degeneration.\
(**A**) Schematic representation of the AAV8-KITL construct. (**B**) Western blots (upper panels) show the expression of KITL in the retina 2 weeks after intraocular injection of AAV8-KITL. The bar graph (lower panels) shows the relative expression of KITL based on the results of western blots. (**C**) Immunostaining images show the immunoreactivity of KITL in 3-month-old *Kit^+/+^* retinas 2 weeks after intraocular injection of AAV8-KITL. (**D**) Histological images of H and E staining from 3-month-old albino retinas infected with AAV8 or AAV8-KITL virus for 2 weeks and then kept under NL (upper panels) or high intensity LD (15,000 lux) continuously for 3 days (lower panels). (**E**) The curve diagram shows the thickness of ONL from albino retinas under NL or high-intensity LD conditions. (**F, G**) Images of TUNEL assays from the retinas (**F**) and bar graph show the cell death rate of photoreceptor cells (**G**) under the indicated conditions. (**H**) Retinal degeneration analysis of 3-month-old *Kit^Wps/Wps^* albino retinas infected with AAV8 or AAV8-KITL virus for 2 weeks and then kept under high-intensity LD by HE staining (upper panels) and TUNEL detection (down panels). (**I**) The curve diagram shows the thickness of the photoreceptor cell layer from the indicated retinas. (**J**) Quantification of the rate of cell death in the ONL of the indicated retinas. GCL, ganglion cell layer; INL, inner nuclear layer; ONL outer nuclear layer; ONH, optic nerve head; PL, photoreceptor cell layer. \*\* indicates p\<0.01. Scale bar: 50 μm.\
Figure 4---source data 1.Source data for the diagrams in Figure 4E, I and the graphs in Figure 4G, J.](elife-51698-fig4){#fig4}

In order to test whether overexpression of *Kitl* would affect retinal damage after light exposure, we had to avoid the complication that C57BL/6 mice are homozygous for the *Rpe65^L450M^* mutation, which, as mentioned above, leads to increased resistance to LIRD ([@bib60]). Hence, for these experiments, we used albino mice, which are *Rpe65* wildtype. Without LD, neither AAV8 (schematically shown in [Figure 4---figure supplement 2A](#fig4s2){ref-type="fig"}) nor AAV8-KITL caused detectable changes of retinal morphology in these mice ([Figure 4D,E](#fig4){ref-type="fig"}). After 3 days of LD treatment, retinas infected by AAV8-KITL were thicker than those infected by control AAV8 or left uninfected ([Figure 4D,E](#fig4){ref-type="fig"}). Furthermore, TUNEL analysis showed that infection with AAV8 control or AAV8-KITL virus did not cause photoreceptor cell death under normal light conditions, but under LD conditions, photoreceptor cell death was less pronounced when AAV8-KITL was used (9 ± 1.6%, n = 6) compared to when control AAV8 was used (40.8 ± 4.5%, n = 6) or the eyes were left uninfected (37.7 ± 5%, n = 6) ([Figure 4F,G](#fig4){ref-type="fig"}). These results suggest that AAV8-KITL prevents light-induced photoreceptor cell death. Immunostaining indeed showed high level KITL expression in photoreceptor cells infected with AAV8-KITL compared to uninfected retinas ([Figure 4---figure supplement 2B](#fig4s2){ref-type="fig"}). Taken together, these data indicate that overexpression of KITL prevents light-induced photoreceptor degeneration in Kit wild type mice.

To investigate whether protection of AAV8-KITL virus indeed depended on KIT, we then used *Kit^Wps/Wps^;Rpe65^+/+^* albino mice, obtained by appropriate crossings of *Kit^Wps^* heterozygotes with BALB/c albino mice and selection of mice homozygous for *Rpe65*^+/+^ by PCR. After 3 days of LD treatment, the retinas in both *Kit^+/+^* albino and *Kit^Wps/Wps^* albino mice showed reduced thickness and near-absence of outer segments, but the effects were more severe in *Kit^Wps/Wps^* albino compared with *Kit^+/+^* albino mice ([Figure 4H,I](#fig4){ref-type="fig"}). Importantly, injection of the AAV8-KITL virus prevented light-induced reduction of retinal thickness in *Kit^+/+^* albino mice but not in *Kit^Wps/Wps^* albino mice ([Figure 4H,I](#fig4){ref-type="fig"}). Consistent with these results, TUNEL assays showed a cell death rate of 40.6 ± 8.2% in *Kit^+/+^* albino mice and 78 ± 11.4% in *Kit^Wps/Wps^* albino mice (n = 4) after control infection, while infection with AAV8-KITL significantly reduced the death rate of photoreceptor cells to 8.9 ± 2.1% in *Kit^+/+^* albino mice but not in *Kit^Wps/Wps^* albino mice, where it remained high (75.9 ± 8.2%, n = 4) ([Figure 4H,J](#fig4){ref-type="fig"}). Collectively, these data suggest that overexpression of KITL can prevent photoreceptor cell death from LD through activation of the receptor KIT.

Overexpression of KITL in photoreceptor cells prevents light-induced retinal degeneration {#s2-5}
-----------------------------------------------------------------------------------------

Although AAV-KITL drives overexpression of KITL predominantly in photoreceptor cells, a protective effect from expression in other cells, even if minor, cannot be entirely excluded. Hence, to test whether the protective effect of KITL is indeed cell-autonomous in photoreceptor cells, we expressed KITL selectively in RPE or photoreceptor cells, using either the RPE-specific promoter RPE65 (AAV8-RPE65-KITL-T2A-Flag, hereafter named AAV8-RPE65-KITL, schematically shown in [Figure 5A](#fig5){ref-type="fig"}) or the photoreceptor cell-specific promoter RHO (AAV8-RHO-KITL, schematically shown in [Figure 5B](#fig5){ref-type="fig"}). As shown in [Figure 5C and D](#fig5){ref-type="fig"}, at 2 weeks after injection of AAV8-RPE65-KITL, overexpression of KITL was prominent in the RPE (12.1 ± 2.4 fold, n = 4), but its protective effect against LD was very limited ([Figure 5E,F](#fig5){ref-type="fig"}). In fact, the death rate of photoreceptor cells was 26.6 ± 5%, n = 8 after infection with AAV8-RPE65-Flag and only slightly reduced to 21.7 ± 2.8%, n = 8 after infection with AAV8-RPE65-KITL ([Figure 5---figure supplement 1A-a and B](#fig5s1){ref-type="fig"}). Hence, overexpression of KITL in RPE does not play a major role in prevention of light-induced photoreceptor degeneration.

![Overexpression of KITL by AAV8-RHO-KITL but not AAV8-RPE65-KITL virus prevents light-induced retinal degeneration.\
(**A**) Schematic representation of the AAV8-RPE65-Flag and AAV8-RPE65-KITL-T2A-Flag constructs. (**B**) Schematic representation of the AAV8-RHO-Flag and AAV8-RHO-KITL constructs. (**C**) Western blots showing expression of KITL in the RPE and neural retina 2 weeks after intraocular injection of AAV8-RPE65-Flag or AAV8-RPE65-KITL-T2A-Flag (left panels). The bar graph shows the relative expression levels of KITL based on the results of western blots (right panels). (**D**) Immunoreactivity of KITL in retina sections of 2-month-old albino mice 2 weeks after intraocular injection of AAV8-RPE65-KITL-T2A-Flag or control AAV8-RPE65-Flag. (**E**) Histological images of H and E staining of retinas infected with the indicated viruses for 2 weeks and then kept under NL or high-intensity LD (15,000 lux) continuously for 3 days. (**F**) The curve diagram shows the thickness of the ONL from albino retinas under the indicated condition. (**G**) Western blots (left panels) and the bar graph (right panels) show the expression of KITL in the RPE and neural retina at 4 weeks after intraocular injection of AAV8-RHO-Flag or AAV8-RHO-KITL virus. (**H**) Immunoreactivity of KITL in retina sections of 2-month-old albino mice 4 weeks after intraocular injection of the AAV8-RHO-Flag or AAV8-RHO-KITL. (**I, J**) Histological images of H and E staining (**I**) and the curve diagram (**J**) showing retinal degeneration under the indicated conditions. GCL, ganglion cell layer; INL, inner nuclear layer; ONL outer nuclear layer; IS, inner segment; OS, outer segment; ONH, optic nerve head. \* or \*\* indicates p\<0.05 or p\<0.01. Scale bar: 50 μm.\
Figure 5---source data 1.Source data for the diagrams in Figure 5E, J.](elife-51698-fig5){#fig5}

Infection with AAV8-RHO-KITL led to overexpression specifically in photoreceptor cells as shown by WB (increase over control by 4.23 ± 0.68 fold, n = 4) and IF ([Figure 5G and H](#fig5){ref-type="fig"}), confirming previous reports ([@bib2]). In contrast to overexpression in RPE, however, overexpression of KITL in photoreceptor cells reduced the LD-induced decrease of ONL thickness ([Figure 5I,J](#fig5){ref-type="fig"}) and prevented photoreceptor cell death (from 25.9 ± 4.7%, n = 8 after infection with AAV8-RHO-Flag to 11.5 ± 2.5%, n = 8 after infection with AAV8-RHO-KITL ([Figure 5---figure supplement 1A-b, C](#fig5s1){ref-type="fig"}). Collectively, these results clearly indicate that overexpression of KITL in photoreceptor cells protects these cells more efficiently than overexpression in RPE cells, underscoring the cell-autonomous effect of KITL.

KIT signaling regulates *Hmox1* expression in photoreceptor cells {#s2-6}
-----------------------------------------------------------------

Studies of human disease and animal models of photoreceptor degeneration have shown that photoreceptor loss is often accompanied by oxidative damage, including irreversible oxidation of DNA and other biomolecules ([@bib8]). In addition, Kit signaling has been identified to regulate mitochondrial function and energy expenditure in brown adipose tissue and skeletal muscle, suggesting that Kit signaling may play a role in oxidation ([@bib25]). Hence, in order to analyze the mechanism by which LD leads to the demise of photoreceptor cells, we focused on oxidative damage. We first analyzed whether a series of antioxidant and wound healing genes would show expression changes in *Kit^+/+^* retinas following LD ([Figure 6A](#fig6){ref-type="fig"}). In fact, after LD, the expression of 17 such genes, including *Axl* and *Hmox1*, was changed in *Kit^+/+^* retinas ([Figure 6B](#fig6){ref-type="fig"}). The protein product of *Hmox1*, HMOX1, catalyzes the degradation of heme into three biologically active end products, biliverdin/bilirubin, CO and ferrous ion ([@bib42]). It is known to be induced by oxidative stress in multiple tissues as well as by LD of the retina ([@bib29]) and thought to act as an antioxidant ([@bib42]). Under normal light/dark cycle conditions, HMOX1 levels analyzed on western blots ([Figure 6C](#fig6){ref-type="fig"}) or by immunostaining ([Figure 6D](#fig6){ref-type="fig"}) were similarly low in both *Kit^+/+^* and *Kit^Wps/Wps^* retinas. After LD, however, HMOX1 expression was significantly upregulated in *Kit^+/+^* retinas (3.6 ± 0.6 fold) but only slightly in *Kit^Wps/Wps^* retinas (1.4 ± 0.5 fold, n = 3) ([Figure 6C,D](#fig6){ref-type="fig"}). These data indicate that LD-dependent upregulation of *Hmox1* is markedly influenced by KIT signaling.

![KIT signaling regulates expression of *Hmox1* in photoreceptor cells.\
(**A**) Venn diagram showing numbers of differentially expressed genes involved in response to oxidative stress and/or wound healing. Results from *Kit+/+* retinas after LD for 1 day. (**B**) Heat-map of differentially expressed genes from the 17 genes common between the wound healing group and response to oxidative stress group according to the result of Venn diagram. Messenger RNA expression changes of anti-oxidant genes in *Kit^+/+^* retinas after LD for 1 day. (**C and D**) Expression of HMOX1 in *Kit^+/+^* and *Kit^Wps/Wps^* retinas were detected by western blots and immunostaining. Note that the expression of HMOX1 was more significantly upregulated in light-degenerated *Kit^+/+^* compared to light-degenerated *Kit^Wps/Wps^* photoreceptors. (**E**) Western blots showing the expression of KITL and HMOX1 in the retinas infected with control AAV8 or AAV8-KITL virus. Bar graphs show the relative expression of KITL and HMOX1 in retinas based on the results of western blots. (**F**) Immunoreactivity of KITL and HMOX1 in *Kit^+/+^* retina sections 1 week after subretinal injection of AAV8-KITL. IS, photoreceptor inner segments; ONL, outer nuclear layer; OS, photoreceptor outer segment. \* or \*\* indicates p\<0.05 or p\<0.01. Scale bar: 50 μm.](elife-51698-fig6){#fig6}

The importance of KIT signaling for the regulation of HMOX1 expression can also be demonstrated in vitro in 661 W cells, which are derived from a medulloblastoma and whose gene expression profiles suggests a photoreceptor origin ([@bib52]). In fact, 661 W cells have been widely used as a tool for investigating photoreceptor cell biology and function ([@bib52]; [@bib61]). To test for the differential effects of Kit-WT and KIT-WPS, we transfected such cells with corresponding expression vectors and treated the cells with KITL. As expected, the ACK2 antibody, which reacts with the extracellular portion of KIT, readily detects KIT after transfection of either of the two KIT vectors ([Figure 6---figure supplement 1A](#fig6s1){ref-type="fig"}). Western blots indicated an increase of 2.9 ± 0.23 fold with Kit-WT and 2.2 ± 0.9 fold with Kit-Wps ([Figure 6---figure supplement 1B](#fig6s1){ref-type="fig"}). Transfection with KIT also led to upregulation of HMOX1, although with a clear difference between KIT-WT (6.2 ± 0.86 fold, n = 4) and KIT-Wps (3 ± 0.6 fold, n = 4). These results are consistent with the in vivo results described above.

Given the in vitro results, we then asked whether ectopic activation of KIT signaling would induce *Hmox1* expression in the retina without LD. Hence, we analyzed the expression of HMOX1 in retinas of *Kit^+/+^* mice kept under normal light conditions and infected with AAV8-KITL virus. One week after injection, western blots showed a correlation between high levels of KITL (4.6 ± 0.9 fold induction, n = 4) and HMOX1 (2.9 ± 0.5 fold induction, n = 4) ([Figure 6E](#fig6){ref-type="fig"}). Consistent with this observation, immunostaining showed that the expression of KITL was dramatically enhanced in the superior retinal region around the location of injection, coinciding with high level HMOX1 expression ([Figure 6F](#fig6){ref-type="fig"}). These data suggest that activation of KIT signaling can induce HMOX1 expression in *Kit^+/+^* retinas independent of LD treatment.

KITL/KIT signaling activates NRF2 to regulate *Hmox1* expression {#s2-7}
----------------------------------------------------------------

To understand how KIT regulates *Hmox1* expression, we analyzed whether KIT signaling is able to regulate the expression of the transcription factor NRF2, an upstream regulator of *Hmox1* that is activated in many cell types in response to stressful environments ([@bib49]; [@bib27]). Although western blots showed no change in NRF2 expression in retinas after light treatment ([Figure 7A,B](#fig7){ref-type="fig"}), immunostaining indicated a dramatic increase in nuclear accumulation of NRF2 in photoreceptor cells after light treatment for 8 days ([Figure 7C](#fig7){ref-type="fig"}). This nuclear accumulation was much reduced in *Kit^Wps/Wps^* mice (14 ± 5 per section, n = 6) compared to *Kit^+/+^* mice (28 ± 9, n = 6) ([Figure 7C,D](#fig7){ref-type="fig"}), suggesting that Kit signaling regulates nuclear translocation of NRF2 in photoreceptor cells.

![KIT signaling acts through the transcription factor NRF2 to regulate *Hmox1* expression.\
(**A**) Western blots for analyzing NRF2 expression in *Kit^+/+^* and *Kit^Wps/Wps^* retinas under the indicated conditions. (**B**) The bar graph shows quantification of NRF2 expression in the indicated retinas. (**C**) Immunostaining of anti-NRF2 in *Kit^+/+^* and *Kit^Wps/Wps^* retinas under the indicated conditions. The arrows point to nuclear signals of NRF2 in the ONL. (**D**) Quantification of the number of nuclear NRF2 positive cells in the retina. Note that LD induced nuclear accumulation of NRF2 in photoreceptor cells. (**E--H**) Analysis of subcellular localization of NRF2 in 661W photoreceptor cells treated with si-*Kitl* by immunostaining (**E**, and **F**) and western blot (**G**, and **H**). Note that knockdown of *Kitl* led to an increase in the proportion of cells with cytosolic NRF2. (**I, J**) Analyses of the regulation of HMOX1 in 661 W cells after overexpression of KIT together with si-*Nfe2l2*. The images of RT-PCR (**I**) and qPCR (**J**) show the expression levels of *Kit*, si-*Nfe2l2*, and *Hmox1* under the indicated treatments. Note that upregulation of *Hmox1* induced by overexpression of KIT was blocked by the knockdown of *Nfe2l2*. \* indicates p\<0.05, \*\* indicates p\<0.01.](elife-51698-fig7){#fig7}

To further examine whether NRF2 nuclear accumulation was dependent on KITL, we used *Kitl*-specific siRNAs to reduce the expression of *Kitl* in 661W photoreceptor cells ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). Indeed, immunostaining revealed that both Kitl-si-RNAs increased the number of cells with cytosolic NRF2 expression from 4.74 ± 2.27% to 30.2 ± 8.3% or 36.8 ± 2.24% (n = 3), respectively ([Figure 7E,F](#fig7){ref-type="fig"}). In addition, western blots showed that knock down of *Kitl* increased the levels of NRF2 in the cytoplasm (1.5 ± 0.13 fold, n = 3) and decreased the levels of nuclear NRF2 (0.59 ± 0.09 fold, n = 3) ([Figure 7G,H](#fig7){ref-type="fig"}). Taken together, these data clearly show that KIT signaling regulates the cytoplasmic/nuclear distribution of NRF2 in photoreceptor cells.

To investigate whether the regulation of *Hmox1* by KIT signaling depends on NRF2, we then used siRNA to knock down *Nfe2l2* mRNA that encodes NRF2 protein in 661 W cells overexpressing KIT ([Figure 7I,J](#fig7){ref-type="fig"}). Consistently, overexpression of KIT did not significantly change *Nfe2l2* expression (1.1 ± 0.2 fold, n = 3) but upregulated *Hmox1* expression (2.35 ± 1 fold, n = 3). This upregulation was blocked by knockdown of *Nfe2l2*. Collectively, these data suggest that KIT signaling activates NRF2 to regulate the expression of *Hmox1* in photoreceptor cells.

*Hmox1* overexpression partially rescues retinal degeneration in light-damaged *Kit* mutant mice {#s2-8}
------------------------------------------------------------------------------------------------

While the above results demonstrated that KIT signaling regulates *Hmox1* expression in the retina and plays a neuroprotective role during LD, the relevant function of HMOX1 in retina in vivo was still unclear. To analyze whether KIT signaling exerts its protective effect against LD through HMOX1, we ectopically expressed *Hmox1* in *Kit^Wps/Wps^* albino mice, using an AAV8-based vector engineered to express HMOX1 ([Figure 8A](#fig8){ref-type="fig"}). Western blotting and immunostaining showed photoreceptor-restricted expression after 2 weeks after virus infection ([Figure 8A,B](#fig8){ref-type="fig"}), with levels similar to those observed in uninjected *Kit^+/+^* retinas after LD. ERG measurements showed that without LD, control AAV8 or AAV8-HMOX1 virus did not cause significant changes in the ERG scotopic trace ([Figure 8C,D](#fig8){ref-type="fig"}). Following 3 days of LD, however, the amplitudes of ERG scotopic traces were depressed after infection with AAV8 or AAV8-HMOX1 virus, but the b-wave amplitudes were higher when AAV8-HMOX1 was used (381 ± 40μV, n = 5) compared to when control AAV8 was used (152 ± 33 μV, n = 5) ([Figure 8C,D](#fig8){ref-type="fig"}). These results suggest that overexpression of HMOX1 partially rescues retinal function in the *Kit^Wps/Wps^* albino mice during LD. Furthermore, histological analyses showed that after LD, AAV8-HMOX1-infected retinas were thicker than control AAV8-infected ones, especially with respect to the photoreceptor cell layer ([Figure 8E,F](#fig8){ref-type="fig"}). These data suggest that overexpression of HMOX1 protects photoreceptor cells in *Kit^Wps/Wps^* albino retinas against LD and that LD-induced HMOX1 plays an important antioxidant role in retinas in vivo.

![Protective role of HMOX1 in LD-treated *Kit^Wps/Wps^* retina.\
(**A**) Schematic representation of the AAV8-HMOX1 construct (upper panel) and western blots show the expression of KITL in the retina 2 weeks after subretinal injection of AAV8- HMOX1 virus (lower panels). The bar graph shows the relative expression of HMOX1 based on the results of western blots. (**B**) Ectopic HMOX1 expression in retina by infection of AAV8 or AAV8-HMOX1 virus was visualized by immunofluorescence (n = 4). (**C**) ERG scotopic traces of *Kit^Wps/Wps^;* albino mice infected with control AAV8 (n = 5) or AAV8-HMOX1 (n = 5) virus for 2 weeks and then kept under NL or high-intensity LD (15,000 lux) for 3 days. (**D**) Quantification of amplitude of b-wave from standard response based on the results from C. (**E**) Histological analysis of *Kit^Wps/Wps^;* albino retina infected with control AAV8 (n = 6) or AAV8-HMOX1 (n = 6) virus after LD. (**F**) Curve diagram showing the total thickness of the ONL under the indicated conditions. GCL, ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer; PL, photoreceptor cell layer. \* or \*\* indicates p\<0.05 or p\<0.01. Scale bar: 50 μm.\
Figure 8---source data 1.Source data for the graphs in Figure 8D and the diagram in Figure 8F.](elife-51698-fig8){#fig8}

To understand whether protection of KITL depends on HMOX1, we used si-*Hmox1* to knockdown the expression of *Hmox1* in 661W photoreceptor cells under light stress. Western blots showed that both Hmox1-si-RNAs downregulate *Hmox1* expression by 0.5 ± 0.2 fold and 0.46 ± 0.23 fold (n = 3), respectively ([Figure 8---figure supplement 1A,B](#fig8s1){ref-type="fig"}). We then tested whether knockdown of *Hmox1* would affect in vitro light-induced cell death. As shown in [Figure 8---figure supplement 1C and D](#fig8s1){ref-type="fig"}, cell numbers were similar in each group before LD but dramatically decreased in the control group (from 409 ± 44 to 147 ± 15 (n = 3) after 8 hr of LD treatment). Addition of exogenous KITL (5.6 nM) was able to prevent cell loss caused by LD to 278 ± 28 (n = 3). This preventive effect was totally blocked by knockdown of *Hmox1* via Hmox1-si-RNAs (cell loss 147 ± 16, n = 3 and 131 ± 17, n = 3, respectively). In addition, the data of propidium iodide (PI) staining also showed that stimulation of KITL decreased light-induced cell death rate from 83 ± 4.6% to 40 ± 5.3% (n = 3), but this protection by KITL disappeared when the expression of *Hmox1* was knocked down by Hmox1-si-RNAs ([Figure 8---figure supplement 1E](#fig8s1){ref-type="fig"}). These results suggest that protection of KITL against light-induced photoreceptor cell loss depends on HMOX1.

KITL preserves photoreceptors and restores retinal function in genetic mouse models of retinal degeneration {#s2-9}
-----------------------------------------------------------------------------------------------------------

We finally evaluated whether KITL might provide neuroprotection in mouse models of human retinitis pigmentosa (RP). Mice homozygous for a mutation in the gene encoding the photoreceptor cGMP phosphodiesterase, *Pde6b^rd10^* (hereafter called *rd10/rd10)* share many characteristics of human retinal degeneration resulting from a mutation in the homologous gene ([@bib56]). Due to the fact that retinas of *rd10/rd10* mice degenerate soon after birth, we performed subretinal injection of AAV8-KITL virus into the eyes of such mice (n = 5) at postnatal day 3 and examined their retinal functions at postnatal day 24. As shown in [Figure 9A](#fig9){ref-type="fig"}, ectopic expression of KITL was observed at 3 weeks in *rd10/rd10* photoreceptor cells in the eye infected with AAV8-KITL, but not in those of the control-injected contralateral eye. These results suggest that subretinal injection of AAV8-KITL virus at P3 can mediate overexpression of KITL in photoreceptor cells of *rd10/rd10* mice. We then analyze the effects of KITL overexpression on retinal degeneration. The thickness of the ONL was significantly increased from the peripheral region to the central region after infection with the AAV8-KITL virus ([Figure 9B,C](#fig9){ref-type="fig"}). In P24 control-injected *rd10/rd10* retina, Rhodopsin was abnormally translocated from the OS to the ONL, a phenomenon that was partially rescued by infection with the AAV8-KITL virus ([Figure 9D](#fig9){ref-type="fig"}). TUNEL analysis showed a large number of dead cells in the ONL of *rd10/rd10* mice infected with control AAV8 virus (death rate, 16.2 ± 2%, n = 5), but a significantly reduced number after AAV8-KITL virus infection (8.9 ± 1.6%, n = 5) ([Figure 9E](#fig9){ref-type="fig"}). We next examined the effects of KITL on retinal function of *rd10/rd10* mice. The ERG analysis revealed that the scotopic traces of control eyes presented nearly horizontal lines (b-wave amplitude, 142.2 ± 43.60.4μV, n = 5), while infection with the AAV8-KITLvirus led to clear a- and b-waves (b-wave amplitude, 304 ± 30μV, n = 5) ([Figure 9F,G](#fig9){ref-type="fig"}), suggesting that overexpression of KITL partially restores the retinal function in *rd10/rd10* mice.

![Ectopic expression of KITL prevents retinal degeneration of *rd10* homozygous mice.\
(**A**) Expression of KITL in *rd10/rd10* retinas 2 weeks after infection with AAV8-KITL virus or control was visualized by immunofluorescence. Note that the subretinal injection was performed in *rd10/rd10* mice at postnatal day 3. (**B and C**) Histological analysis of *rd10/rd10* retinas infected with AAV8 or AAV8-KITL virus (n = 5) or control (**B**). Curve diagram showing the thickness of total photoreceptor cell layer from *rd10/rd10* retina under the indicated conditions (**C**). (**D**) Rhodopsin expression in WT and *rd10/rd10* retina under the indicated conditions. (**E**) Apoptosis of photoreceptor cells from *rd10/rd10* mice with of AAV8 or AAV8-KITL was analyzed by TUNEL assay and is presented as fluorescent images (upper panels) and as bar graphs after quantitation (lower panels). (**F, G**) ERG scotopic traces (**F**) obtained from *rd10/rd10* mice with infection of AAV8-KITL virus (n = 5) or control (n = 5) and kept under normal conditions for 25 days (right panels). Bar graph (**G**) shows the quantification of the amplitude of the b-wave from standard response based on the results of the ERG scotopic traces (**F**). GCL, ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer; PL, photoreceptor layer. \* or \*\* indicates p\<0.05 or p\<0.01. Scale bar: 50 μm.\
Figure 9---source data 1.Source data for the diagram in Figure 9C and the graphs in Figure 9E, G.](elife-51698-fig9){#fig9}

In order to further confirm the protective role of KITL in hereditary photoreceptor degeneration, we used an additional RP model, mice harboring a different mutant allele of *Pde6b*, *Pde6b^rd1^* (hereafter called *rd1/rd1*) that was kept on a different background, FVB. The results were similar to those obtained with *rd10/rd10* mice ([Figure 9---figure supplement 1](#fig9s1){ref-type="fig"}). Taken together, these results strongly indicate that overexpression of KITL prevents photoreceptor cell death and partially restores retinal function not only in LD but also genetic models of retinal degeneration.

Discussion {#s3}
==========

Several lines of evidence support the notion that activation of KIT signaling in photoreceptor cells activates NRF2, in turn inducing expression of HMOX1, and protects these cells against light-induced degeneration. First, KIT is expressed in mouse retina, including in its photoreceptor cells, and its activation leads to stimulation of the MAPK and the PI3K/AKT pathways. Second, photoreceptor cells respond to prolonged high-level light exposure by upregulating their endogenous KITL expression, which activates KIT signaling in these cells. Third, when KITL is experimentally overexpressed in *Kit^+/+^* retina, it alleviates the effects of LD. Fourth, when KIT signaling is genetically impaired, photoreceptor cells are more susceptible to LD, and this enhanced susceptibility cannot be overcome by additional experimental upregulation of KITL. Fifth, experimental expression of HMOX1 in photoreceptor cells in vivo partially protects these cells against light damage even when their KIT signaling pathway is impaired. Sixth, experimental overexpression of KITL also partially protects against photoreceptor cell loss in *Kit^+/+^* mice harboring mutations in *Pde6b*, the mouse homolog of the human RP gene, whose mutations are associated with retinal degeneration in both mice and humans.

Given these findings, the use of KITL and activation of KIT signaling may add to the arsenal of endogenous pathways that may be considered clinically for photoreceptor protection during retinal degeneration. Indeed, in contrast to other strategies such as stem cell therapies, optogenetics and retinal prostheses, which all face major technical and financial investments ([@bib48]), the application of endogenous neuroprotective factors would seem to provide a more straightforward therapeutic avenue, with the added benefit that it may work regardless of the actual pathogenetic mechanism underlying photoreceptor degradation ([@bib43]). AAV-mediated expression of neurotrophic factors or antioxidant genes such as RdCVF and NRF2 has indeed proved beneficial in protecting photoreceptors ([@bib32]; [@bib36] [@bib63]), and similar strategies using KIT activation may prove equally valuable.

Previous studies have indicated, however, that Kit signaling can have both beneficial and deleterious effects ([@bib31]). On the one hand, KIT is needed for cell development and survival ([@bib4]; [@bib22]; [@bib58]), but on the other hand, excessive KIT signaling, associated, for instance, with activating *KIT* mutations, may also lead to formation of tumors, in particular gastrointestinal stromal tumors, adult acute myeloid leukemia, and melanoma ([@bib31]). Hence, activation of KIT signaling should be used with caution in clinical settings. Nevertheless, local expression of KITL following intraocular injection of recombinant AAV might considerably reduce potential deleterious effects because gene expression is locally restricted and transfer of protein to other tissues is effectively blocked by the blood retinal barrier. In addition, the optimal choice of virus promoters and doses reduces the risk of virus-induced retinal damage ([@bib64]). Nevertheless, before any further use of KITL in a clinical setting is entertained, it is paramount to establish the precise pathway of its action in the retina.

In the current paper we have so far shown that it is KITL activation in photoreceptor cells themselves, rather than in RPE cells or potentially other retinal cells, that has protective effects on retinal degeneration, and that it is cell-autonomous KITL action that protects photoreceptor cells against degeneration. Nevertheless, other cell types also express KIT ([@bib28]; [@bib67]; [@bib53]). Among them are Müller glial cells, which have been reported to participate in reactive gliosis and regulate retinal repair during retinal injury ([@bib53]; [@bib16]). Therefore, it cannot be excluded that cells such as Müller glial cells indirectly help to mediate KITL action on photoreceptor cells. Such an indirect, non-cell autonomous effect of a cellular receptor, EDNRB (the receptor for endothelin-3), has been observed, for instance, in neural crest-derived melanocytes ([@bib23]).

We have also shown that the pathway downstream of KIT involves a cytoplasm-to-nuclear shift of the transcription factor NRF2, which is likely mediated by KIT signaling-dependent activation of AKT ([@bib65]). Moreover, KIT signaling leads to increased expression of HMOX1 in an NRF2-dependent way. The involvement of HMOX1 seems particularly interesting as it can reduce oxidative stress by breaking down heme and reducing molecular oxygen and oxygen radicals in the heme oxygenase reaction pathway ([@bib42]). Photoreceptor cells have a rich complement of mitochondria to accommodate their high metabolic rate and are more sensitive to oxidative stress than many other cell types ([@bib5]). The development of AMD, for instance, is tightly linked to oxidative damage ([@bib39]), and antioxidant therapy can delay cell loss in retinal degenerative diseases and lead to reduced photoreceptor cell death in experimental animals ([@bib12]; [@bib21]). Oxidative stress has also been observed in many other neurodegenerative conditions, including LIRD, and antioxidant treatment is useful in their prevention ([@bib12]; [@bib51]; [@bib63]). The induction of *Hmox1* following LD ([@bib19]) can therefore be seen as a homeostatic mechanism operating in photoreceptor cells ([@bib50]). Nevertheless, it is important to recognize that in our model, KITL overexpression or isolated overexpression of HMOX1 did not lead to full protection against LD. Hence, the KITL-KIT-NRF2-HMOX1 axis that we here identified is likely only one among many pathways involved in protection of photoreceptor cells against LD.

In summary, our findings provide strong evidence for KIT signaling in protecting photoreceptor cells against light-induced retinal damage as well as against inherited forms of retinal degeneration. We believe that these findings justify a detailed exploration of how this signaling pathway could be harnessed pharmacologically for prevention or delay of progressive photoreceptor cell and vision loss as seen in AMD, RP and other retinal degenerations. Hence, the findings have implications not only for our understanding of the relationship between genetic and environmental factors in retinal degeneration in general but also as a potential treatment for photoreceptor loss in humans.

Materials and methods {#s4}
=====================

Mice and histology {#s4-1}
------------------

All animal experiments were carried out in accordance with approved guidelines of the Wenzhou Medical University Institutional Animal Care and Use Committee (Permit Number: WZMCOPT-090316). C57BL/6J mice were obtained from The Jackson Laboratory and *Kit^Wps^* mice carrying a point mutation in the extracellular domain of KIT on a C57BL/6J background were as previously described ([@bib18]). Because *Kit^Wps^* homozygotes are infertile, crosses between *Kit^Wps^* heterozygotes were set up to obtain *Kit^Wps/Wps^* mice. To obtain appropriate *Kit^Wps/Wps^* albino mice, we crossed B6-*Kit^Wps/+^;Rpe65^L450M/L450M^* mice with BALB/c albino mice (*Tyr^c^/Tyr^c^;Rpe65^+/+^*) to eventually obtain *Kit^Wps/Wps^;Tyr^c^/Tyr^c^;Rpe65^+/+^* mice. For genotyping, the *Kit* gene was amplified with Kit-F and Kit-R, and the Rpe65 gene was amplified with Rpe65-F5 and Rpe65-R ([Supplementary file 1](#supp1){ref-type="supplementary-material"}: Key Resources Table) as previously described ([@bib18]; [@bib60]). *rd1* (*Pde6b^rd1^*, FVB genetic background) and *rd10* (*Pde6b^rd10^*, C57BL/6J genetic background) mice were purchased from Vital River Laboratory (Beijing, China) and Jackson Laboratory. All mice were fed a standard laboratory chow and maintained at 21--23°C with a 12 h-light/12 hr-dark photoperiod.

Enucleated eyes from euthanized mice were fixed in 4% paraformaldehyde (PFA) overnight at RT and paraffin-embedded according to standard procedures. Paraffin sections (5 μm thickness) were prepared using a Leica microtome, deparaffinized by immersion in Xylene, and rehydrated. The sections were stained with hematoxylin for 5 min and eosin for 3 min and mounted using resinene. The thickness of *Kit^+/+^* and *Kit^Wps/Wps^* retinas was measured in the dorsal central region at a distance between 300 and 700 μm from the optic nerve head.

In vivo light injury and RNA-seq analysis {#s4-2}
-----------------------------------------

For light-induced retinal damage, 2-month-old albino mice were first dark-adapted for 12 hr and then exposed to LED light (15,000 lux) in non-reflective cages for the indicated number of days. For *Kit^+/+^* and *Kit^Wps/Wps^* mice, 3-month-old mice were first dark-adapted for one day and then exposed to LED light (15,000 lux) in non-reflective cages for the indicated number of days. During light exposure, mice were allowed free access to food and water. For ERG measurements, mice were dark-adapted for 1 day after light exposure.

For RNA-seq analysis, total RNAs of neural retinas were extracted using TRIzol reagent (Invitrogen) after 1 day of light exposure following the time frame shown in [Figure 1A](#fig1){ref-type="fig"}. Purified RNA samples were used to generate RNA libraries for HiSeq 4000 (PE150 sequence). Experiments and data normalization were performed by Beijing Novogene (China). The raw data of RNA seq were deposited to the GEO database (GSE146176) and are available online (<https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE146176>).

Electroretinography {#s4-3}
-------------------

Retinal function was evaluated by electroretinography (ERG) as previously described ([@bib35]). Briefly, mice were dark-adapted overnight and anesthetized with a mixture of ketamine and xylazine. The pupils were dilated and the corneas were anesthetized with atropine sulfate and proparacaine hydrochloride. Then a silver loop electrode was placed over the cornea to record the ERGs, while needle reference and ground electrodes were inserted into the cheek and tail, respectively. Mice were stimulated by flash light varying in intensity from −5.0 to 35 log scotopic candlepower-sec/m^2^ in a Ganzfeld dome (Roland Q400, Wiesbaden, Germany). For light-adapted ERG recordings, a background light of 30 cd/m^2^ was applied for 5--10 min to suppress rod responses. The stimulus light intensity was attenuated with neutral density filters (Kodak, Rochester, NY) and luminance was calibrated with an IL-1700 integrating radiometer/photometer (International Light, Newburyport, MA).

Cell cultures, light damage, siRNA and transfection {#s4-4}
---------------------------------------------------

The 661W photoreceptor cell line was generously provided by Dr. Muayyad Al-Ubaidi (Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK). The cells were routinely cultured in Dulbecco's modified Eagle's medium (Gibco) supplemented with 10% FBS and 1% penicillin/streptomycin and kept at 37°C in a humidified atmosphere with 5% CO~2~. 661 W cell line was tested negative for mycoplasma contamination by the MycoProbe Mycoplasma detection Kit (Cat\# CUL001B, R&D) and positive for photoreceptor cell marker Recoverin and Opsin by IF.

For LD, 661W photoreceptor cells were kept at 37°C in a humidified atmosphere with 5% CO2 and exposed to high-intensity light (9000 lux) for 8 hr. Then the cells were subjected to cell count analysis and PI staining (1:200, Sigma).

For siRNA knockdown, specific siRNAs for mouse *Nfe2l2*, *Hmox* or *Kitl* and a negative control siRNA were designed and produced by Gene-Pharma (GenePharma, China). 20 nM si- *Nfe2l2*, si-*Hmox1* or si-*Kitl* was transfected into 661 W cells at 40% confluency in culture dishes using LipoJetin vitro transfection Kit (SignaGen Laboratories) according to the manufacturer's protocol. An equivalent amount of control siRNA (si--C) was used as a negative control. The sequences for all siRNAs are shown in [Supplementary file 1](#supp1){ref-type="supplementary-material"}: Key Resources Table.

For DNA transfections, plasmids of pCDNA3.1-encoding either KIT^WT^ cDNA or KIT^Wps^ cDNA were from Dr. Xiang Gao (Nanjing University). 661 W cells were seeded in six-well plates at 7.5 × 10^4^ cells/well before transfection. When the cell density reached 30% confluence, cells were transfected with appropriate dilutions of 2 μg plasmid DNA using PolyJet reagent (SignaGen) at the indicated concentrations following the company's instructions.

Western blots and assays of protein phosphorylation {#s4-5}
---------------------------------------------------

For analysis of phosphorylation of KIT, mice were anesthetized with a mixture of ketamine and xylazine, and 1 μl of KITL (5.6 nM) was intravitreally injected into the eye. One hour thereafter, neural retinas were isolated and subjected to western blot analysis. For protein extraction, retinas were isolated in DMEM and transferred to 1.5 ml centrifuge tubes containing a mixture (100 μl) of membrane protein lysis solution (Byotime, China) and protease inhibitors (Cocktail Set I, Calbiochem). Retinas were lysed on ice for 10 min with a Micro Tissue Grinder. Samples were separated by 8% SDS-PAGE and the blotting process was previously described ([@bib33]). Information of antibodies used in western blot is shown in [Supplementary file 1](#supp1){ref-type="supplementary-material"}: Key Resources Table. These antibodies were used at 4°C overnight. The quantification of the protein bands was done using the software of Image J.

For isolated RPE and photoreceptor tissue, RPE sheets were isolated from 2-month-old C57BL/6J mice as described previously ([@bib14]) and then subjected to western blotting analysis. The neural retinas were isolated in Hanks solution and then freshly frozen in OCT compound. The photoreceptor layer was at the bottom of the embedding block. The first cryosection of neural retina (30 μm) was transferred to 1.5 ml centrifuge tubes containing a mixture (30 μl) of membrane protein lysis solution and then subjected to western blotting analysis as described above.

For cell protein extraction, cells were washed with 1 × PBS and then lysed by membrane protein lysis solution on ice. In addition, we used cell fractionation kit-standard (Abcam, ab109719) to extract cytoplasmic and nuclear proteins and performed the analysis according to the standard protocols.

RT-PCR and quantitative RT- PCR {#s4-6}
-------------------------------

Total neural retinal RNA or total RPE RNA was extracted by Trizol reagent (Invitrogen) according to the manufacturer's protocol. Total RNA for RT-PCR was converted to cDNA with a reverse transcriptase kit and random primers (Promega), according to the manufacturer's manual. PCR products were size-fractionated by 2% agarose gel electrophoresis. The procedure for quantitative RT-PCR has been described ([@bib33]). Sequences of primers used in this study are shown in [Supplementary file 1](#supp1){ref-type="supplementary-material"}: Key Resources Table.

Immunohistochemistry and TUNEL assay {#s4-7}
------------------------------------

Information on the antibodies used in immunofluorescence (IF) is shown in [Supplementary file 1](#supp1){ref-type="supplementary-material"}: Key Resources Table. For immunoassays of KITL, KIT, EAAT1, Flag and HMOX1, eyes were freshly embedded in OCT compound and snap frozen. Cryosections (14 μm) were post-fixed in ice-cold acetone for 15 min and permeabilized with 0.1% Triton-X-100 for 10 min. Rat anti-KIT (ACK45), goat anti-EAAT1, rabbit anti-Flag, goat anti-KITL and rabbit anti-HMOX1 antibodies were used at 4°C overnight and Alexa 488-conjugated donkey anti-rat, anti-goat or anti-rabbit antibodies were used at RT for 1 hr. The sections were examined and photographed with a Zeiss fluorescence microscope.

For other immunoassays, the corneas were penetrated with a needle in 1 × PBS and the eyes fixed in 4% PFA for 1 hr at RT. The sections (5 μm) were heated in boiled citrate buffer for 2 min for epitope retrieval. Primary antibodies were: mouse anti-rhodopsin, rabbit anti-opsin, mouse anti-PKCα, rabbit anti-OTX2, goat anti-KITL, rabbit anti-KIT (AB5506), rabbit anti NRF2 and rabbit anti-GFAP. The antibodies were all used at RT for 2 hr. The primary antibodies were revealed with Alexa 594-conjugated donkey anti-mouse or anti-rabbit and Alexa 488-conjugated donkey anti-goat or anti-mouse antibodies at RT for 1 hr.

Cultured cells were fixed in 4% PFA for 25 min at RT and permeabilized with 0.1% Triton X-100. 5% BSA was used to block the samples at RT for 30 min. Rat anti-KIT (ACK2) antibody was used at RT for 2 hr.

For TUNEL assays, in situ cell death detection kit (Roche, Mannheim, Germany) was used according to the manufacturer's protocol.

AAV8 vector construction and virus injection {#s4-8}
--------------------------------------------

For the AAV8-CMV-KITL vector, the vector of pcDNA3.0-*Kitl* was a gift from Dr. Bernhard Wehrle-Haller (University of Geneva, Switzerland). The coding sequence of the mouse *Kitl* was cloned from the vector and inserted into the AAV2/8-CMV-MCS empty vector (Genechem, China). For the AAV8-RPE65-KITL-T2A-Flag vector, GGCAGCGGCGAGGGCAGAGGAAGTCTTCTAACATGCGGTGACGTGGAGGTCCCGGCCCT of the T2A the sequence was linked to the coding sequence of *Kitl* at the 3' terminus and then inserted into the AAV2/8-RPE65-MCS-Flag vector (Genechem, China). For AAV8-RHO-KITL and AAV8-RHO-Flag vector, we first replaced the CMV promoter sequence of the AAV2/8-CMV-MCS vector with the Human RHO promoter sequence (GeneBank accession number: U16824) to obtain the AAV2/8-RHO-MCS vector according to previous report ([@bib2]) and then inserted the coding sequence of the mouse *Kitl* or Flag into the AAV2/8-RHO-MSC empty vector. For AAV8-CMV-Hmox1 vector, the coding sequence of the mouse *Hmox1* gene was amplified by reverse transcription PCR using the primers for Hmox1-F and Hmox1-R as shown in Supplemental Table S1. The full-length cDNA of *Hmox1*was cloned from *Kit^+/+^* retinal total cDNA and inserted into the AAV2/8-CMV-MCS empty vector (Genechem, China) via *Age*I restriction sites introduced by the PCR reaction. The AAV8-CMV-GFP vector was purchased from Genechem Company (Shanghai, China).

Virus was injected into the subretinal space as previously described ([@bib63]). Approximately 0.5 μl of AAV8 supernatant (2.2 × 10^12^ genome copies/ml) was introduced into the subretinal space of 2- to 3-month-old mice using a pulled angled glass pipette under direct observation aided by a dissecting microscope under dim light. Following injections, 1% atropine eye drops, tetracycline, and cortisone acetate eye ointments were applied. For subretinal injection, neonatal *rd1* and *rd10* mice were kept on ice for 2 min and then subretinally injected with approximately 0.3 μl of AAV8 using micro-injection glass pipettes.

In situ hybridization {#s4-9}
---------------------

Retinas from 2-month-old albino mice kept under normal light or high intensity light for 1 day were collected in PBS and fixed overnight at 4°C using 4% paraformaldehyde (PFA). In situ hybridization was performed according to previous report ([@bib6]). The *Kitl* riboprobes was obtained using pcDNA3.0-*Kitl* (gift from Dr. Bernhard Wehrle-Haller).

Statistical analysis {#s4-10}
--------------------

Data are from at least three replicates for each experimental condition and are represented as mean ± standard deviation (SD). Analysis of variance (ANOVA) was used to determine the significance between population means. Student' s t-test was used to determine the significance of differences when only two groups were compared. p\<0.05 was considered to be statistically significant. Significant differences between groups are noted by \*or \*\*.
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

Your paper is significant as it reports the discovery that activation of the *Kitl*/SCF pathway is an early stress response to photoreceptor degeneration, upstream of NRF2/HMOX1. The fact that it is providing protection to light damage makes it clinically relevant and this should be of interest to the readership of *eLife*.

**Decision letter after peer review:**

Thank you for submitting your article \"KIT ligand protects against both light-induced and genetic photoreceptor degeneration\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Marianne Bronner as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

The three reviewers appreciated the discovery that activation of the *Kitl*/SCF pathway is an early stress response to photoreceptor degeneration, upstream of NRF2/HMOX1, and that it is providing protection to light damage. The clinical relevant of this observation is therefore very high.

However, the reviewers noticed a number of important points that must be addressed before the paper can be considered for publication:

1\) First, you must show that the effect in autonomous and not driven by the RPE where. Using cell specific promoters to rescue the phenotype would allow you to address this point. The three reviewers were concerned about this point that must absolutely be addressed.

2\) One reviewer was also concerned with the use of the 661W tumor cell line that might not be appropriate for these experiments. Have you used any other cell line? In any case, this must be discussed in the paper.

3\) There were also concerns about the quality of the Western blots, although the reviewers believe that, considering the difficulty to perform these experiments on retinal extract, they might not be perfect. However, you should discuss the specificity of the antibodies and try to show better images. The specificity of these antibodies might have been partially demonstrated by the blots of AAV-mediated KITL or HMOX1 overexpression in the eye and transfection of KIT^WT^ or *Kit^Wps^* in the cell line.

4\) The problem appears more serious with the IF data and these must be improved to convince the reviewers that what you are trying to demonstrate. In particular, the RPE must absolutely be included in the images.

5\) As mentioned above, the cell specificity of the AAV virus must be better demonstrated as cell autonomy is such an important point of the paper.

6\) The ERGs might also need to be improved.

Reviewer \#1:

The *Kitl/Kit* pathway has not been well studied in the eye. The findings of this group that activation of the *Kitl/Kit* pathway is one of the early stress responses to photoreceptor degeneration and that it is the upstream of NRF2-dependent HMOX1 upregulation are novel. The authors provided strong evidence that the *Kitl/Kit* pathway is necessary and sufficient to provide protection to photoreceptors following light damage. Further study using genetic retinal degeneration mouse models indicated a generic protective effect of that *Kitl/kit* pathway, which may have impact on RP treatment. Overall, I found that this manuscript delivers high quality data and is clearly written. The results are compelling and have appropriate quantifications whenever possible.

One part of the story that is less clear to me is whether the activation of the KITL/KIT pathway in the photoreceptors is in a cell-autonomous manner or not. The authors suggested that it is the photoreceptors upregulating *kitl* following light damage or AAV-KITL infection. What is the expression level of *kitl* and kit in the RPE vs. retina in uninjured eyes? And have the authors examined the *kitl* expression in the RPE following light damage by qPCR or immunostaining (Figure 1I used retinal section without RPE)? In terms of the rescue experiment by viral vectors, AAV-CMV vector also drives strong transgene expression in the RPE cells, which is evident in Figure 4---figure supplements 1 and 2. The strong staining of *Kitl* in the OS is likely from the cilia of the RPE cells. This is also obvious in Figure 5F, where KITL and HMOX1 overexpression are not overlapping. What the authors can do in the future is to use RPE-specific or photoreceptor-specific promoters to drive *Kitl* expression and examine the rescue effects. As for this manuscript, I think that the authors should discuss the possible involvement of RPE and/or the other cell types in the retina in the activation of the KITL/KIT pathway.

Reviewer \#2:

The manuscript by Li et al. focuses on the role of KIT/KITL signaling in photoreceptors of the retina as it relates to response to light damage. Light damage in a sensitive mouse strain leads to increased signaling through the KITL/KIT/MAPK pathway. They used a Kit hypomorphic allele on pigmented and albino mouse strains to show that signaling through this pathway is necessary to protect photoreceptors. In addition, AAV delivery was used to demonstrate that ectopic KITL expression could partially protect photoreceptors using their light damage model. Additional experiments were focused on elucidating the other components of the pathway such as HMOX1 and NRF2. Those studies were primarily ectopic expression and knockdown experiments. The authors used in vivo mouse models but also a cell line from a mouse tumor (661W). The strengths of the manuscript include the emphasis on in vivo studies and the potential impact on a major human disease. The limitations are scientific rigor, use of the retinoblastoma 661W cell line and incomplete experimental details. Specific comments include:

1\) Throughout the manuscript, the western blots are not convincing and data to demonstrate specificity of the antibodies should be provided.

2\) Throughout the manuscript, the immunofluorescence data are not convincing. The photoreceptor inner segments are a common site of non-specific staining and efforts should be made to demonstrate specificity and localization of the signal. For example, it is impossible to distinguish inner segments from Muller apical microvilli in their images.

3\) Controls should be included to definitively demonstrate which cells are infected with the AAV vector. AAV8 should infect all cell types and they did not provide convincing data on photoreceptor specificity. This is important because cell autonomous versus non-autonomous signaling is an important distinction for KITL/KIT signaling.

4\) The 661W cell line is a mouse retinoblastoma with features of multiple cell types and this is not an appropriate proxy for normal cells.

5\) The in vivo rescue was not well controlled. How many mice were used, how long were they followed, empty vector was not used in all experiments as should have been done.

Reviewer \#3:

The authors present a detailed report exploring novel genetic factors associated with light induced damage of photoreceptor cells. The authors identify a gene previously unassociated with light damage, KITL (KIT Ligand, also known as SCF, SLF), as upregulated following light damage. This leads to activation of its receptor, KIT (also known as CD117, c-KIT), and down-stream signaling pathways. Inactivation of the KIT pathway using a genetic mutant results in worsening of light induced photoreceptor loss. Over-expression of KITL in photoreceptors via AAV transduction can protect against light induced damage, but not in animals lacking functioning KIT. The authors identify HMOX1 as a potential downstream target of KIT signaling as a factor important for mediating this protective effect. They show that activation of the KIT pathway with either light damage or over-expression of KITL results in upregulation of HMOX1. This effect on HMOX1 appears to be regulated through nuclear translocation of NRF2 which is inhibited in KIT deficient animals. The authors then show that over-expression of HMOX1 via AAV transduction is sufficient to partially protect photoreceptors from light induced damage. Finally, the authors show that activation of the KIT signaling pathway through over-expression of KITL is capable of protecting photoreceptors in two models of retinitis pigmentosa.

Overall the manuscript is well written with strong supporting evidence for the claims stated. The experiments are presented in a logical order with convincing data. I would recommend this manuscript for publication after revision.

I highly suggest giving the manuscript an additional editing pass for spelling and grammar as well as wording of some sentences (e.g. The sentence \"We observed that after 2 weeks of injection, high-level KITL expression was restricted to photoreceptor cells and the RPE...\" implies that the injections were performed for 2 weeks, when in reality they were done once and then the animals were followed up 2 weeks later. There are numerous occasions of this type of phrasing and other similar examples that are confusing and detract from the overall manuscript).

I would also ask that the authors revisit their Discussion and explore more rationale as to the protective effect of KIT signaling on photoreceptors. The authors mainly restate their results and do not spend anytime analyzing how HMOX1 could be mediating its protective effect and this discussion is necessary to explain how KIT signaling can be protective. The authors also need to address alternative pathways downstream of KIT that may also be contributing to photoreceptor protection. The authors admit that HMOX1 is only capable of partially rescuing photoreceptors. Are there other pathways which may be of interest to examine next?

There are several ERG graphs that show only noisy traces which are not useful for assaying retinal function (Figure 3B, Kit+/+ no light damage photopic; Figure 8F, AAV8-KITL transduced *rd10* homozygous animals; Figure 9---figure supplement 1B, both traces). If these panels are representative of all data collected for these experiments then they would either need to be repeated or omitted from the manuscript. The associated morphological data is sufficient to show a protective effect of KITL/damaging effect of removing KIT signaling without needing ERG data to show functional deficits.

Is the AAV8 construct used for HMOX1 identical to the one used for KITL (besides the gene)? If so, why is there such broad expression of HMOX1 compared to KITL after transduction? The promoter used is CMV so one would expect broad expression in most cells of the retina.

KIT appears to be mainly expressed on the inner segments of photoreceptors while KITL appears to be mainly expressed on the outer segments of photoreceptors/RPE villi. Do photoreceptors normally express KITL or is this exogenously supplied by RPE during stress? Could the authors provide an in situ hybridization showing if KITL is expressed in photoreceptors or in RPE (or both)?
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Author response

> However, the reviewers noticed a number of important points that must be addressed before the paper can be considered for publication:
>
> 1\) First, you must show that the effect in autonomous and not driven by the RPE where. Using cell specific promoters to rescue the phenotype would allow you to address this point. The three reviewers were concerned about this point that must absolutely be addressed.

We appreciate your and your reviewers' comments. According to your suggestion, we have performed additional experiments and provide stronger evidence supporting the conclusion that photoreceptor cells upregulate KITL expression to prevent photoreceptor degeneration during light damage. Firstly, based on the results of gene expression analysis by qPCR, WB, IF and ISH, we show that photoreceptor cells upregulate *Kitl* expression in response to light damage (see new Figure 1I, Figure 1---figure supplement 2 and Figure 1---figure supplement 3). The details are described in the revised Results section (subsection "Light damage upregulates endogenous KITL in photoreceptor cells", last paragraph). Secondly, we expressed KITL specifically in photoreceptor cells or RPE cells, using AAV8 viruses allowing for KITL expression either under the control of the photoreceptor cell-specific promoter RHO (AAV8-RHO-KITL) or the RPE cell-specific promoter RPE65 (AAV8-RPE65-KITL), and analyzed its effect on LD (see new Figure 5，Figure 5---figure supplement 1). The results are consistent with the view that it is predominantly KITL generated in photoreceptors and not KITL generated in RPE cells that protects photoreceptors against LD. In other words, KITL acts in an autocrine and not paracrine fashion. The results are described in the subsection "Overexpression of KITL in photoreceptor cells prevents light-induced retinal degeneration".

> 2\) One reviewer was also concerned with the use of the 661W tumor cell line that might not be appropriate for these experiments. Have you used any other cell line? In any case, this must be discussed in the paper.

We appreciate your suggestions and understand the reviewer's concerns. As far as we know, the 661W cell line is the only cell line representing photoreceptor cells, and it has been widely used for investigations of photoreceptor cell biology and function (Tan et al., 2004). Recently, Wheway et al. have performed whole transcriptome RNA sequencing of 661W cells and showed that 661W cells originated from photoreceptor cells and can be used as a cell model for studying retinal ciliopathies (Wheway et al., 2019). We, therefore, reasoned that 661W cells serve as an appropriate model of photoreceptor cells for in vitro studies, designed principally to support our main in vivo results. According to your suggestion, we have modified the original sentence in the Results section (subsection "KIT signaling regulates *Hmox1* expression in photoreceptor cells", second paragraph). To further address your concern, we also isolated primary photoreceptor cells from C57BL/6J mice at P7 to examine the relationship between KITL/KIT and *Hmox1* ([Author response image 1](#respfig1){ref-type="fig"}). The IF data show that a high proportion of the primary retinal cells expressed photoreceptor specific marker Rhodopsin ([Author response image 1A](#respfig1){ref-type="fig"}), suggesting they are photoreceptor cells. In response to stimulation of KITL, the primary cells not only upregulated phosphorylated KIT ([Author response image 1B](#respfig1){ref-type="fig"}), but also turned on *Hmox1* expression ([Author response image 1C and D](#respfig1){ref-type="fig"}). These results are consistent with the studies in 661W cell line. However, we do not think that addition of this figure would add more relevant information to the main message of our manuscript.

![KITL induces *Hmox1* expression in primary retinal cells.\
(**A**) Representative immunostaining images of anti-Rhodopsin in cultured retinal cells from C57BL/6J mice at P7. (**B**) Western blots show the levels of phosphorylated KIT after stimulation with KITL in the primary cells. (C, D) The expression analysis of *Hmox1* in the primary cells after stimulation with KITL through RT-PCR (**C**) and qPCR (**D**) examination (n=3). \* or \*\* indicates *p*\<0.05 or *p*\<0.01. Bar: 50 μm.](elife-51698-resp-fig1){#respfig1}

> 3\) There were also concerns about the quality of the Western blots, although the reviewers believe that, considering the difficulty to perform these experiments on retinal extract, they might not be perfect. However, you should discuss the specificity of the antibodies and try to show better images. The specificity of these antibodies might have been partially demonstrated by the blots of AAV-mediated KITL or HMOX1 overexpression in the eye and transfection of KIT^WT^ or Kit^Wps^ in the cell line.

We appreciate your and your reviewers' suggestions. We have further analyzed the specificity of the anti-KITL antibody through overexpression of KITL in 661W cell line by AAV8-KITL and human recombinant KITL peptides ([Author response image 2](#respfig2){ref-type="fig"}). The IF and WB data consistently show that the antibody is specific to KITL ([Author response image 2A and B](#respfig2){ref-type="fig"}). However, we do not think that addition of this figure would add more relevant information to the main message of our manuscript. In addition, the data of IF and WB from the retinas infected by AAV8-RPE65-KITL-T2A-Flag virus also showed that the KITL antibody can specifically recognize the KITL protein in the retina (see new Figure 5C,D). The specificity of other antibodies can also be seen by which tissue is stained (see new Figure 1---figure supplement 3B). For instance, MITF is known to be an RPE-specific marker and Rhodopsin a photoreceptor cell specific marker. Furthermore, overexpression in vivo or in vitro serves as quality control for the KIT and HMOX1 antibodies (see Figure 6---figure supplement 1 and Figure 8A, B). To improve the quality of the western blots, we repeated most of the corresponding experiments and replaced previous images with improved ones (Figure 2I; Figure 2---figure supplement 1A; Figure 4A; Figure 6C, E; Figure 7A; Figure 8A).

![Analysis of the anti-KITL antibody in photoreceptor cells.\
(**A**) Immunostaining images of anti-KITL in 661W photoreceptor cells infected with AAV8 (left panel) or AAV8-KITL (right panel) virus. (**B**) Western blots show the specific recognition of the anti-KITL antibody to Human recombinant KITL protein (18 kDa). (**C**) Immunostaining images of Goat anti-IgG (left panels) and Goat anti-KITL (right panels) in the retinas from 2-month-old albino mice kept under normal light or LD (15, 000 Lux) condition for 1 day. GCL, ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer. Bar: 50 μm.](elife-51698-resp-fig2){#respfig2}

> 4\) The problem appears more serious with the IF data and these must be improved to convince the reviewers that what you are trying to demonstrate. In particular, the RPE must absolutely be included in the images.

We appreciate your and your reviewers' suggestions. For KITL expression, we have repeated the IF experiments of anti-KITL in LD treated retinas and provide new improved images that include photoreceptor cells and RPE (see new Figure 1I). To further analyze the specificity of the anti-KITL antibody, we used IgG antibody as a negative control ([Author response image 2C](#respfig2){ref-type="fig"}). To avoid non-specific staining in the photoreceptor inner segment, we isolated photoreceptor tissue from frozen sections as shown in Figure 1---figure supplement 3A and then used western blotting to detect KITL by anti-KITL antibody (see Figure 1---figure supplement 3B, C). In addition, *Kitl* expression in photoreceptor cells was also confirmed by the data of in situ hybridization using a *Kitl* probe (see Figure 1---figure supplement 3D). All of these data support the notion that KITL is indeed expressed in photoreceptor cells.

For KIT expression, we also repeated the IF experiment with anti-KIT (AB5506) in the retina and replaced the original image with a new one (see new Figure 2---figure supplement 1B). To analyze whether KIT immunoreactivity signal in the photoreceptor layer is from Müller glia cells, we performed double immunostaining with anti-KIT antibody (ACK45) and anti-EAAT1 antibody (Müller glia-specific marker) in C57BL/6J mice and *rd10/rd10* mice (whose photoreceptor cells are vastly diminished) at postnatal 2 month (see Figure 2---figure supplement 2). The results showed that KIT immunoreactivity in the photoreceptor layer is unlikely to come from interdigitating apical microvilli of Müller glial cells. The results are described in the second paragraph of the subsection "The *Kit^Wps^* mutation does not cause detectable changes in retinal function and structure but disrupts KIT activation in the retina".

> 5\) As mentioned above, the cell specificity of the AAV virus must be better demonstrated as cell autonomy is such an important point of the paper.

We appreciate your suggestion and have performed corresponding experiments as described above in the response to Editor comment 1. The data (see new Figure 5 and Figure 5---figure supplement 1) indicate that overexpression of KITL in photoreceptor cells prevents light-induced retinal degeneration (subsection "Overexpression of KITL in photoreceptor cells prevents light-induced retinal degeneration").

> 6\) The ERGs might also need to be improved.

We have repeated the ERG examination and replaced previous images with improved images (Figure 3B; Figure 9F; Figure 9---figure supplement 1B) in this revision.

> Reviewer \#1:
>
> \[...\] One part of the story that is less clear to me is whether the activation of the KITL/KIT pathway in the photoreceptors is in a cell-autonomous manner or not. The authors suggested that it is the photoreceptors upregulating kitl following light damage or AAV-Kitl infection. What is the expression level of kitl and kit in the RPE vs. retina in uninjured eyes? And have the authors examined the kitl expression in the RPE following light damage by qPCR or immunostaining (Figure 1I used retinal section without RPE)?

We appreciate your comments. According to your suggestions, we have examined KITL expression in RPE and photoreceptor cells of light-injured retinas or uninjured retinas. The gene expression analysis, including q-PCR, IF, WB and ISH (see new Figure 1I, Figure 1---figure supplement 2 and Figure 1---figure supplement 3), consistently showed that photoreceptor cells are able to upregulate *Kitl* expression in response to light stress (subsection "Light damage upregulates endogenous KITL in photoreceptor cells", last paragraph).

> In terms of the rescue experiment by viral vectors, AAV-CMV vector also drives strong transgene expression in the RPE cells, which is evident in Figure 4---figure supplements 1 and 2. The strong staining of Kitl in the OS is likely from the cilia of the RPE cells. This is also obvious in Figure 5F, where KITL and HMOX1 overexpression are not overlapping. What the authors can do in the future is to use RPE-specific or photoreceptor-specific promoters to drive Kitl expression and examine the rescue effects.

We appreciate your great comment. According to your suggestions, we now utilized the photoreceptor cell-specific promoter RHO (AAV8-RHO-KITL) and RPE cell-specific promoter RPE65 (AAV8-RPE65-KITL) to drive KITL expression separately in the respective cell types and then analyzed the effects on LIRD (see new Figure 5, Figure 5---figure supplement 1 and the response as described above in the Editor comment 1). Indeed, KITL exerts its protective role when expressed in photoreceptors and not when expressed in the RPE. The results are described in the subsection "Overexpression of KITL in photoreceptor cells prevents light-induced retinal degeneration".

> As for this manuscript, I think that the authors should discuss the possible involvement of RPE and/or the other cell types in the retina in the activation of the KITL/KIT pathway.

We appreciate your suggestions. We now discuss this point in the Discussion section of the revision (fourth paragraph).

> Reviewer \#2:
>
> 1\) Throughout the manuscript, the western blots are not convincing and data to demonstrate specificity of the antibodies should be provided.

We appreciate your suggestions and have further analyzed the specificity of the anti-KITL antibody through overexpression of KITL in 661W cell line by AAV8-KITL and the human recombinant KITL peptides as you can see from [Author response image 2](#respfig2){ref-type="fig"} and the response as described above to Editor comment 3. In addition, the data of IF and WB from the retinas infected by AAV8-RPE65-KITL-T2A-Flag virus also showed that the KITL antibody specifically recognizes KITL protein in the retina (see new Figure 5C, D). As mentioned above, the specificity of other antibodies can also be seen by which tissue is stained (see new Figure 1---figure supplement 3B). For instance, MITF is known to be an RPE-specific marker and Rhodopsin a photoreceptor cell specific marker.

Furthermore, overexpression in vivo or in vitro serves as quality control for the KIT and HMOX1 antibodies (see Figure 6---figure supplement 1 and Figure 8A, B). To improve the quality of the western blots, we repeated most of them and replaced previous images with improved images (Figure 2I; Figure 2---figure supplement 1A; Figure 4A; Figure 6C, E; Figure 7A; Figure 8A).

> 2\) Throughout the manuscript, the immunofluorescence data are not convincing. The photoreceptor inner segments are a common site of non-specific staining and efforts should be made to demonstrate specificity and localization of the signal. For example, it is impossible to distinguish inner segments from Muller apical microvilli in their images.

We appreciate your suggestions. For KITL expression, we have repeated the IF experiment of anti-KITL in LD treated retinas and replaced the former figure with a new and improved image which includes photoreceptor cells and RPE (Figure 1I). To further analyze the specificity of the anti-KITL antibody in the retina, we used IgG antibody as a negative control. The IF data showed that the immunoreactivity signal of anti-KITL antibody was increased in the photoreceptor cells after LD treatment, while the immunoreactivity signal of anti-IgG antibody was not observed in the photoreceptor cells ([Author response image 2](#respfig2){ref-type="fig"} and response to Editor comment 3 described above). To avoid the non-specific staining in the photoreceptor inner segment by IF, we isolated photoreceptor tissue from frozen sections as shown in Figure 1---figure supplement 3A and used western blotting to examine KITL using the anti-KITL antibody. The western blots showed that the level of KITL protein is much higher in the photoreceptor cells than in RPE cells (Figure 1---figure supplement 3B, C). In addition, *Kitl* expression in photoreceptor cells was confirmed by in situ hybridization using a Kitl probe (Figure 1---figure supplement 3D). These data indicate that KITL is expressed in photoreceptor cells.

For KIT expression, we also repeated the IF experiment using anti-KIT (AB5506) on the retina and replaced the original image with an improved one (Figure 2---figure supplement 1B). To analyze whether KIT immunoreactivity signal in the photoreceptor layer is from Müller glia cells, we performed double immunostaining with anti-KIT antibody (ACK45) and anti-EAAT1 antibody (Müller glia-specific marker) in C57BL/6J mice and *rd10/rd10* mice with their vastly diminished photoreceptor cells at postnatal 2 month (see Figure 2---figure supplement 2). The results showed that the KIT immunoreactivity in the photoreceptor layer is unlikely to come from interdigitating apical microvilli of Müller glial cells. The results are described in detail in the Results section (subsection "The *Kit^Wps^* mutation does not cause detectable changes in retinal function and structure but disrupts KIT activation in the retina", second paragraph).

> 3\) Controls should be included to definitively demonstrate which cells are infected with the AAV vector. AAV8 should infect all cell types and they did not provide convincing data on photoreceptor specificity. This is important because cell autonomous versus non-autonomous signaling is an important distinction for KITL/KIT signaling.

We appreciate your suggestions. For control groups, we first analyzed the effect of AAV8-CMV empty vector or AAV8-CMV-Flag on light-induced photoreceptor degeneration. The 2-month-old albino mice were infected by the virus for 2 weeks and then exposed to NL or high-intensity light for 3 days. At 2 weeks post-infection, IF data showed that AAV8-CMV-Flag virus successfully drove Flag expression in photoreceptor cells and RPE. After LD of 3 days, the photoreceptor degeneration in the retinas infected by AAV8-CMV-Flag was similar to that in the retinas infected by the AAV8-CMV-empty, suggesting that AAV8-CMV-empty can be used as an appropriate control virus ([Author response image 3](#respfig3){ref-type="fig"}). Due to the fact that AAV8-CMV-empty has already been used as a control virus in the original version, we still used AAV8-CMV empty virus as a control virus in *Kit^Wps/Wps^* albino mice kept under NL or high-intensity light condition in this revision. In addition, we also injected AAV8-CMV empty virus into the eyes of *rd1* and *rd10* mice as control groups and replaced all uninjected groups with the injection of AAV8-CMV empty virus in this revision (Figure 4H-J; Figure 9; Figure 9---figure supplement 1).

![The effect of AAV8-Flag virus on the LIRD is similar to that of AAV8 empty virus.\
(**A**) Immunostaining images of anti-Flag in the retinas from 2-month-old albino mice 2 weeks after intraocular injection of AAV8 or AAV8-Flag virus. (B, C) Histological analysis ofretinas from the albino mice infected with AAV8 or AAV8-Flag and kept under NL or LD (15, 000 Lux) condition for 3 days (n=5) (**B**) and the curve diagram (**C**) showing the thickness of ONL fromthe *albino* retinas under the indicated conditions. GCL, ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer; IS, inner segment; OS, outer segment. \*\* indicates *p*\<0.01. Bar: 50 μm.](elife-51698-resp-fig3){#respfig3}

For the cell specificity of KITL overexpression, according to your suggestion, we utilized photoreceptor cell specific promoter RHO (AAV8-RHO-KITL) or RPE cell specific promoter RPE65 (AAV8-RPE65-KITL) to drive KITL expression in photoreceptor cells and RPE cells, respectively, and then analyzed the effects of these two viruses on LIRD (see new Figure 5, Figure 5---figure supplement 1 and the response as described above in the Editor comment 1). Both viruses successfully drove overexpression of KITL in RPE and photoreceptor cells, respectively. Indeed, it is KITL from photoreceptor cells and not from the RPE that is protective for photoreceptor cells. The results are in the subsection "Overexpression of KITL in photoreceptor cells prevents light-induced retinal degeneration".

> 4\) The 661W cell line is a mouse retinoblastoma with features of multiple cell types and this is not an appropriate proxy for normal cells.

We appreciate your comment and understand your concerns. Please see the response to Editor comment 2 above.

> 5\) The in vivo rescue was not well controlled. How many mice were used, how long were they followed, empty vector was not used in all experiments as should have been done.

We appreciate your suggestions and apologize for the lack of clarity. As mentioned above, for this revision, we used AAV8-CMV empty virus as a control virus and replaced all uninjected groups with AAV8-CMV empty virus injected control groups (Figure 4H-J; Figure 9; Figure 9---figure supplement 1). Regarding the in vivo rescue experiments, for *rd10/rd10*, we performed subretinal injection of AAV8-KITL virus into the eyes of such mice (n=5) at postnatal day 3 and examined their retinal functions at postnatal day 24 (subsection "KITL preserves photoreceptors and restores retinal function in genetic mouse models of retinal degeneration"). For *rd1/rd1* mice, the subretinal injection was performed (n=5) at postnatal day 1. The mice were kept under normal environmental condition for 20 days and then subjected to retinal degeneration analysis (figure legend of Figure 9---figure supplement 1). For LD treatment, the information can be found in the corresponding part of the Results section.

> Reviewer \#3:
>
> \[...\] I highly suggest giving the manuscript an additional editing pass for spelling and grammar as well as wording of some sentences (e.g. The sentence \"We observed that after 2 weeks of injection, high-level KITL expression was restricted to photoreceptor cells and the RPE...\" implies that the injections were performed for 2 weeks, when in reality they were done once and then the animals were followed up 2 weeks later. There are numerous occasions of this type of phrasing and other similar examples that are confusing and detract from the overall manuscript).

We appreciate your comments and are sorry for the confusion. We have replaced all sentences "after 2 weeks of injection" statements with "2 weeks after injection of the virus" throughout this revised manuscript.

> I would also ask that the authors revisit their Discussion and explore more rationale as to the protective effect of KIT signaling on photoreceptors. The authors mainly restate their results and do not spend anytime analyzing how HMOX1 could be mediating its protective effect and this discussion is necessary to explain how KIT signaling can be protective. The authors also need to address alternative pathways downstream of KIT that may also be contributing to photoreceptor protection. The authors admit that HMOX1 is only capable of partially rescuing photoreceptors. Are there other pathways which may be of interest to examine next?

We appreciate your comments and apologize for the insufficient information. We have revisited our Discussion according to your suggestions and discussed the action model of KITL/KIT in photoreceptor cells, the potential manner by which HMOX1 could protect photoreceptor cells against LD, the regulation of relationship between the KITL/KIT and NRF2-HMOX1 axis and the limitation of this work (Discussion, fourth paragraph).

> There are several ERG graphs that show only noisy traces which are not useful for assaying retinal function (Figure 3B, Kit+/+ no light damage photopic; Figure 8F, AAV8-KITL transduced rd10 homozygous animals; Figure 9---figure supplement 1B, both traces). If these panels are representative of all data collected for these experiments then they would either need to be repeated or omitted from the manuscript. The associated morphological data is sufficient to show a protective effect of KITL/damaging effect of removing KIT signaling without needing ERG data to show functional deficits.

According to your suggestions, we have repeated the ERG examination and replaced the previous images with improved ones (Figure 3B; Figure 9F; Figure 9---figure supplement 1B).

> Is the AAV8 construct used for HMOX1 identical to the one used for KITL (besides the gene)? If so, why is there such broad expression of HMOX1 compared to KITL after transduction? The promoter used is CMV so one would expect broad expression in most cells of the retina.

We appreciate the reviewer's comment. The basic vector of AAV8-HMOX1 contains a CMV promoter and is the same as that of AAV8-KITL. This AAV8-CMV vector has been reported to drive gene expression mainly in photoreceptor cells and RPE (Xiong et al., 2015). Our data also show that AAV8-KITL drives KITL expression mainly in photoreceptor cells and RPE. Similarly, we have repeated the examination of HMOX1 expression in the retinas infected by AAV8-HMOX1 and found that HMOX1 expression is mainly restricted to photoreceptor cells (see new Figure 8B in this revision).

> KIT appears to be mainly expressed on the inner segments of photoreceptors while KITL appears to be mainly expressed on the outer segments of photoreceptors/RPE villi. Do photoreceptors normally express KITL or is this exogenously supplied by RPE during stress? Could the authors provide an in situ hybridization showing if KITL is expressed in photoreceptors or in RPE (or both)?

We appreciate the reviewer's comment. According to your suggestions, we have examined KITL expression in RPE and photoreceptor cells of light-injured or uninjured retinas by gene expression analysis, including in situ hybridization (see new Figure 1I, Figure 1---figure supplement 2 and Figure 1---figure supplement 3). The data consistently show that photoreceptor cells upregulate *Kitl* expression in response to light stress (subsection "Light damage upregulates endogenous KITL in photoreceptor cells", last paragraph). In addition, to analyze the cell specificity of the protective role of KITL, we used the photoreceptor cell-specific promoter RHO (AAV8-RHO-KITL) or the RPE cell-specific promoter RPE65 (AAV8-RPE65-KITL) to drive KITL expression in photoreceptor cells and RPE cells, respectively (see new Figure 5, Figure 5---figure supplement 1 and the response as described above in the Editor comment 1). Indeed, KITL exerts its protective role when expressed in photoreceptors and not when expressed in the RPE. The results are described in the subsection "Overexpression of KITL in photoreceptor cells prevents light-induced retinal degeneration".
